| Andrew Saik |
Andrew Saik is currently the Chief Financial Officer at Intercept Pharmaceuticals, Inc. He previously held the same position at VYNE Therapeutics, Inc. and has also served as the Chief Financial Officer at PDS Biotechnology Corp., Auxilium Pharmaceuticals LLC, Edge Therapeutics, Inc., and Vertice Pharma LLC. He was the Senior Vice President-Finance at Bausch Health Americas, Inc. and the Treasurer & Senior Vice President-Finance at Endo Health Solutions, Inc. He started his career as a Finance Manager at nexgenIX, Inc. Mr. Saik holds an MBA from the University of Southern California and an undergraduate degree from the University of California, Los Angeles. |
| Linda M. Richardson |
Linda M. Richardson is currently the Chief Commercial Officer & Executive VP at Intercept Pharmaceuticals, Inc. She previously worked as the Director at the National Women's Health Resource Center, Inc. and as the Vice President-Marketing at Reliant Pharmaceuticals LLC. From 2014 to 2018, she served as the Chief Strategy & Commercial Officer at Chimerix, Inc. Prior to that, she was the Vice President at Sanofi SA from 2008 to 2013. Ms. Richardson also held a position as Vice President-Marketing at GlaxoSmithKline LLC. She completed her undergraduate degree at the University of Pennsylvania. |
| Paolo Fundarò |
Currently, Paolo Fundarò holds the position of Chairman of Intercept Pharmaceuticals, Inc. and Chief Executive Officer at Genextra SpA. He is also on the board of 5 other companies.
He previously occupied the position of Managing Director & Director at Tethis SpA, Managing Director at Congenia Srl, Managing Director at Dac SRL, Principal at Credit Suisse (USA), Inc., Director-Finance & Strategic Planning at Fastweb SpA and Principal at Salomon Smith Barney International Ltd.
He received an undergraduate degree from the University of Bocconi. |
| M. Michelle Berrey |
M. Michelle Berrey is currently the Director at The North Carolina Biotechnology Center, Director at Noveome Biotherapeutics, Inc., Director at Virion Therapeutics LLC, Independent Director at Ocean Biomedical, Inc. (United States), Independent Director at Ocean Biomedical, Inc., and Chief Medical Officer & President-Research at Intercept Pharmaceuticals, Inc. She previously held positions as President, Chief Executive & Medical Officer at Chimerix, Inc., Chief Medical Officer & VP-Clinical Development at Pharmasset, Inc., and VP-Viral Diseases & Clinical Pharmacology at GSK Plc. Berrey received her undergraduate and graduate degrees from Emory University and her doctorate from Georgia Health Sciences University. |
| Jerome B. Durso |
Jerome B. Durso is currently the Chief Executive Officer at Intercept Pharmaceuticals, Inc. and the President & Chief Executive Officer at Intercept Pharma International Ltd. Previously, he served as the Director at Somerset Medical Center, Inc. and as the Chief Commercial Officer & Senior Vice President at Sanofi-Aventis U.S. LLC. He also held the position of Chief Commercial Officer at Sanofi-Synthelabo, Inc. from 1993 to 2015. Mr. Durso completed his undergraduate degree at the University of Notre Dame. |
